Amethyst Spivak

Amethyst Spivak

UNVERIFIED PROFILE

Are you Amethyst Spivak?   Register this Author

Register author
Amethyst Spivak

Amethyst Spivak

Publications by authors named "Amethyst Spivak"

Are you Amethyst Spivak?   Register this Author

4Publications

70Reads

50Profile Views

Telepsychiatry Use in U.S. Mental Health Facilities, 2010-2017.

Psychiatr Serv 2020 Feb 16;71(2):121-127. Epub 2019 Oct 16.

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore (S. Spivak, Cullen, Meuchel, Johnston, Mojtabai); National Trafficking Shelter Alliance, Baltimore (A. Spivak); Department of Mental Health, Johns Hopkins University School of Public Health, Baltimore (Cullen, Mojtabai); Johns Hopkins Health Systems, Baltimore (Chernow, Green).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ps.201900261DOI Listing
February 2020

Prescription opioid use among individuals with serious mental illness.

Psychiatry Res 2018 09 31;267:85-87. Epub 2018 May 31.

Johns Hopkins University School of Medicine, 405 N. Caroline St, Baltimore, MD 21231, USA; Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2018.05.075DOI Listing
September 2018

Exposure to Direct-to-Consumer Pharmaceutical Advertising and Medication Nonadherence Among Patients With Serious Mental Illness.

Psychiatr Serv 2017 Dec 15;68(12):1299-1302. Epub 2017 Sep 15.

Ms. Green, Dr. Mojtabai, Dr. Cullen, Ms. Mitchell, and Dr. Spivak are with the Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore. Dr. Mojtabai and Dr. Cullen are also with the Bloomberg School of Public Health, Johns Hopkins University, Baltimore. Ms. Spivak is with The Samaritan Women, Baltimore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ps.201700035DOI Listing
December 2017

Interrater reliability of the modified Monitoring of Side Effects Scale for assessment of adverse effects of psychiatric medication in clinical and research settings.

J Clin Psychopharmacol 2015 Jun;35(3):324-8

From the *Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine; †Community General Psychiatry Division, Johns Hopkins Bayview Medical Center; ‡Department of Medical Informatics, Kennedy Krieger Institute; §Department of Mental Health, Johns Hopkins Bloomberg School of Public Health; ∥Laboratory for Neurocognitive Imaging Research, Kennedy Krieger Institute, Baltimore, MD; ¶The Lewin Group, Falls Church VA; #School of Nursing, Johns Hopkins University; **Francis King Carey School of Law, University of Maryland; and ††Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0000000000000311DOI Listing
June 2015